A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles

By Out Henk J.  

Human Reproduction, Vol. 16, Iss. 6, 2001-06 ,pp. : 1104-1109

Oxford University Press

Access to resources Recommend Favorite

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

By Devroey P.   Boostanfar R.   Koper N.P.   Mannaerts B.M.J.L.   IJzerman-Boon P.C.   Fauser B.C.J.M.  

Human Reproduction, Vol. 24, Iss. 12, 2009-12 ,pp. : 3063-3072

Oxford University Press

Access to resources Recommend Favorite

The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial

By Mavrelos Dimitrios   Ben-Nagi Jara   Davies Anthony   Lee Christopher   Salim Rehan   Jurkovic Davor  

Human Reproduction, Vol. 25, Iss. 9, 2010-09 ,pp. : 2264-2269

Oxford University Press

Access to resources Recommend Favorite

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial*Dr Olivennes and Dr Leader presented data from the study at ESHRE, Berlin, 2004 and ASRM, Philadelphia, 2004.

By Lambalk C.B.   Leader A.   Olivennes F.   Fluker M.R.   Andersen A. Nyboe   Ingerslev J.   Khalaf Y.   Avril C.   Belaisch-Allart J.   Roulier R.   Mannaerts B.  

Human Reproduction, Vol. 21, Iss. 3, 2006-03 ,pp. : 632-639

Oxford University Press

Access to resources Recommend Favorite

Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study

By Blockeel C.   De Vos M.   Verpoest W.   Stoop D.   Haentjens P.   Devroey P.  

Human Reproduction, Vol. 24, Iss. 11, 2009-11 ,pp. : 2910-2916

Oxford University Press

Access to resources Recommend Favorite